A First in Human Study of AX-202 in Healthy Subjects and Patients With Psoriasis.

Clinical trial NCT05965089 · COMPLETED

Trial details

NCT number: NCT05965089
Sponsor: Arxx Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers Mild to Moderate Psoriasis

Start date: 2023-04-25
Primary completion: 2024-07-31
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.